Adamian R T, Markosian K M
V.A. Fanarjyan Center for Cancer Research, Yerevan.
Vopr Onkol. 2001;47(1):52-4.
Starting from stage I-II, patients with endometrial tumors (ET) revealed a significant decline (p < 0.05) in counter-suppression lymphocytes as compared to healthy subjects of the same age. The correlation was particularly marked in cases of stage III-IV tumors (p < 0.01).
从I-II期开始,子宫内膜肿瘤(ET)患者与同龄健康受试者相比,其反抑制淋巴细胞显著减少(p < 0.05)。在III-IV期肿瘤病例中,这种相关性尤为明显(p < 0.01)。